Pediatrics Doctors in Slidell, LA Accepting Medicare

23 Pediatrics doctors found. Showing 21 - 23

Lan T Dang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Medical Center Dr, Slidell, LA 70461 Phone: 985-646-1580

Madhuri Deepak Dixit, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1340 14th St, Slidell, LA 70458 Phone: 985-601-0410    Fax: 985-649-8703

Dr. Tara Theresa Deeney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2370 Gause Blvd E, Slidell, LA 70461 Phone: 985-639-3755

News Archive

Bill Gates seeks additional $1.5B in donations for polio eradication efforts

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "is seeking a further $1.5 billion in donations to wipe out polio by 2018 and make it the first infectious disease eradicated since smallpox was wiped from the planet in 1979".

PharmaVentures announces global expansion of PharmaDeals Agreements

PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

Brain-derived neurotrophic factor may inhibit glucose intolerance after cerebral ischemia

Interestingly, a recent study found that ischemic stress causes hyperglycemia and may worsen ischemic neuronal damage. In addition, decreased insulin sensitivity after ischemic stress seems to be involved in the development of post-ischemic glucose intolerance.

E-cigarettes: New route to conventional smoking and nicotine addiction for teenagers

E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UC San Francisco study.

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)